Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Maslak

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Leukemia|June 25, 1998
A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemiaM A Weiss, P Drullinsky, P Maslak, et al.
Oncology (Williston Park, N.Y.)|November 1, 1996
NCCN Acute Leukemia Practice Guidelines. The National Comprehensive Cancer NetworkM R O'Donnell, F Appelbaum, M Bishop, et al.
Leukemia|January 1, 1994
Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experienceR P Warrell, P Maslak, A Eardley, et al.
Leukemia|June 1, 1994
Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experienceR P Warrell, P Maslak, A Eardley, et al.
Blood|March 15, 1993
CD2 expression and PML/RAR-alpha transcripts in acute promyelocytic leukemiaP Maslak, W H Miller, G Heller, et al.
Blood|December 1, 1994
Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acidL Vahdat, P Maslak, W H Miller, et al.
Leukemia|December 17, 2005
Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndromeP Maslak, S Chanel, L H Camacho, et al.
Spine|November 27, 2019
Can the American College of Surgeons Risk Calculator Predict 30-day Complications After Spine Surgery?Michael H McCarthy, Partik Singh, Rusheel Nayak, et al.
Leukemia|September 20, 2000
Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapyM A Weiss, M Glenn, P Maslak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisoneM Weiss, P Maslak, E Feldman, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Leukemia|June 25, 1998
A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemiaM A Weiss, P Drullinsky, P Maslak, et al.
Oncology (Williston Park, N.Y.)|November 1, 1996
NCCN Acute Leukemia Practice Guidelines. The National Comprehensive Cancer NetworkM R O'Donnell, F Appelbaum, M Bishop, et al.
Leukemia|January 1, 1994
Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experienceR P Warrell, P Maslak, A Eardley, et al.
Leukemia|June 1, 1994
Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experienceR P Warrell, P Maslak, A Eardley, et al.
Blood|March 15, 1993
CD2 expression and PML/RAR-alpha transcripts in acute promyelocytic leukemiaP Maslak, W H Miller, G Heller, et al.
Blood|December 1, 1994
Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acidL Vahdat, P Maslak, W H Miller, et al.
Leukemia|December 17, 2005
Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndromeP Maslak, S Chanel, L H Camacho, et al.
Spine|November 27, 2019
Can the American College of Surgeons Risk Calculator Predict 30-day Complications After Spine Surgery?Michael H McCarthy, Partik Singh, Rusheel Nayak, et al.
Leukemia|September 20, 2000
Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapyM A Weiss, M Glenn, P Maslak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisoneM Weiss, P Maslak, E Feldman, et al.
Pageof 4